Drug - Menadione
The trade name of the product as shown on the labeling.

The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Menadione
Multiple ingredients are in alphabetical order.

Strength - 5MG
The potency of the active ingredient(s), Menadione. May repeat for multiple part products.

Applicant - LILLY
The firm name holding legal responsibility for Menadione. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 002139
The FDA assigned number to Menadione. Format is nnnnnn.

Product Number - 003
The FDA assigned number to identify Menadione. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Menadione was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Menadione. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Menadione is in. Format is RX, OTC, DISCN.

Applicant Full Name - Eli Lilly And Co
The full name of the firm holding legal responsibility for the new application of Menadione.